Evolent Health faces volatility with missed targets and 2024 guidance cuts. Click here for a full investment analysis of EVH stock.
Healthcare solutions company Evolent Health (NYSE:EVH) will be reporting results tomorrow after market close. Here’s what to expect. Evolent Health missed analysts’ revenue expectations by 1% ...
Dedicated employee costs primarily include project management and technology staff costs needed to migrate acquired businesses to Evolent's integrated technology platform and costs related to the ...
ARLINGTON, Va. (AP) — ARLINGTON, Va. (AP) — Evolent Health Inc. (EVH) on Thursday reported a loss of $22.8 million in its fourth quarter. The Arlington, Virginia-based company said it had a ...
Citizens JMP raised the firm’s price target on Evolent Health (EVH) to $13 from $12 and keeps an Outperform rating on the shares. Evolent’s Q4 revenue trailed consensus, while adjusted EBITDA ...
Piper Sandler lowered the firm’s price target on Evolent Health (EVH) to $16 from $17 and keeps an Overweight rating on the shares. The firm says the company reported Q4 results at the low end ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results